Shingrix Tied to Higher Risk of Ophthalmic Shingles Recurrence
(MedPage Today) -- The recombinant zoster vaccine (RZV; Shingrix) was associated with a significantly increased risk of recurrence of herpes zoster ophthalmicus (HZO), according to a retrospective cohort study.
Within 56 days after the start of...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news
More News: Herpes | Infectious Diseases | Opthalmology | Shingles | Shingles (Herpes Zoster) Vaccine | Study | Vaccines | Varicella-Zoster Virus Vaccine